Risperidone long-acting injection (LAI)
Sponsors
Janssen-Ortho Inc., Canada
Conditions
Psychotic DisordersSchizoaffective DisorderSchizophreniaSchizophreniform Disorder
Phase 4
A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
CompletedNCT00246259
Start: 2004-10-31End: 2008-12-31Updated: 2013-12-11
A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication
TerminatedNCT00256997
Start: 2006-01-31End: 2009-04-30Updated: 2013-12-05